Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 4
1979 1
1981 2
1982 2
1985 2
1986 3
1987 3
1988 5
1989 7
1990 2
1991 3
1992 5
1993 2
1994 4
1995 11
1996 7
1997 8
1998 3
1999 9
2000 1
2001 4
2002 2
2003 5
2004 9
2005 8
2006 6
2007 3
2008 8
2009 11
2010 8
2011 11
2012 11
2013 16
2014 16
2015 18
2016 14
2017 18
2018 24
2019 10
2020 18
2021 9
Text availability
Article attribute
Article type
Publication date

Search Results

284 results
Results by year
Filters applied: . Clear all
Page 1
Genetics of rheumatoid arthritis contributes to biology and drug discovery.
Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, Graham RR, Manoharan A, Ortmann W, Bhangale T, Denny JC, Carroll RJ, Eyler AE, Greenberg JD, Kremer JM, Pappas DA, Jiang L, Yin J, Ye L, Su DF, Yang J, Xie G, Keystone E, Westra HJ, Esko T, Metspalu A, Zhou X, Gupta N, Mirel D, Stahl EA, Diogo D, Cui J, Liao K, Guo MH, Myouzen K, Kawaguchi T, Coenen MJ, van Riel PL, van de Laar MA, Guchelaar HJ, Huizinga TW, Dieudé P, Mariette X, Bridges SL Jr, Zhernakova A, Toes RE, Tak PP, Miceli-Richard C, Bang SY, Lee HS, Martin J, Gonzalez-Gay MA, Rodriguez-Rodriguez L, Rantapää-Dahlqvist S, Arlestig L, Choi HK, Kamatani Y, Galan P, Lathrop M; RACI consortium; GARNET consortium, Eyre S, Bowes J, Barton A, de Vries N, Moreland LW, Criswell LA, Karlson EW, Taniguchi A, Yamada R, Kubo M, Liu JS, Bae SC, Worthington J, Padyukov L, Klareskog L, Gregersen PK, Raychaudhuri S, Stranger BE, De Jager PL, Franke L, Visscher PM, Brown MA, Yamanaka H, Mimori T, Takahashi A, Xu H, Behrens TW, Siminovitch KA, Momohara S, Matsuda F, Yamamoto K, Plenge RM. Okada Y, et al. Among authors: kremer jm. Nature. 2014 Feb 20;506(7488):376-81. doi: 10.1038/nature12873. Epub 2013 Dec 25. Nature. 2014. PMID: 24390342 Free PMC article.
Leflunomide.
Cannon GW, Kremer JM. Cannon GW, et al. Among authors: kremer jm. Rheum Dis Clin North Am. 2004 May;30(2):295-309, vi. doi: 10.1016/j.rdc.2004.01.010. Rheum Dis Clin North Am. 2004. PMID: 15172042 Review.
Transcriptome landscape of a bacterial pathogen under plant immunity.
Nobori T, Velásquez AC, Wu J, Kvitko BH, Kremer JM, Wang Y, He SY, Tsuda K. Nobori T, et al. Among authors: kremer jm. Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):E3055-E3064. doi: 10.1073/pnas.1800529115. Epub 2018 Mar 12. Proc Natl Acad Sci U S A. 2018. PMID: 29531038 Free PMC article.
Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial.
Burmester GR, Kremer JM, Van den Bosch F, Kivitz A, Bessette L, Li Y, Zhou Y, Othman AA, Pangan AL, Camp HS. Burmester GR, et al. Among authors: kremer jm. Lancet. 2018 Jun 23;391(10139):2503-2512. doi: 10.1016/S0140-6736(18)31115-2. Epub 2018 Jun 18. Lancet. 2018. PMID: 29908669 Clinical Trial.
Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study.
Pappas DA, St John G, Etzel CJ, Fiore S, Blachley T, Kimura T, Punekar R, Emeanuru K, Choi J, Boklage S, Kremer JM. Pappas DA, et al. Among authors: kremer jm. Ann Rheum Dis. 2021 Jan;80(1):96-102. doi: 10.1136/annrheumdis-2020-217209. Epub 2020 Jul 21. Ann Rheum Dis. 2021. PMID: 32719038 Free PMC article.
Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON).
Smolen JS, Kremer JM, Gaich CL, DeLozier AM, Schlichting DE, Xie L, Stoykov I, Rooney T, Bird P, Sánchez Bursón JM, Genovese MC, Combe B. Smolen JS, et al. Among authors: kremer jm. Ann Rheum Dis. 2017 Apr;76(4):694-700. doi: 10.1136/annrheumdis-2016-209821. Epub 2016 Oct 31. Ann Rheum Dis. 2017. PMID: 27799159 Free PMC article. Clinical Trial.
A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis.
Weinblatt ME, McInnes IB, Kremer JM, Miranda P, Vencovsky J, Guo X, White WI, Ryan PC, Godwood A, Albulescu M, Close D, Burmester GR. Weinblatt ME, et al. Among authors: kremer jm. Arthritis Rheumatol. 2018 Jan;70(1):49-59. doi: 10.1002/art.40323. Arthritis Rheumatol. 2018. PMID: 28941039 Free PMC article. Clinical Trial.
Methotrexate Pulmonary Toxicity: Deep Inspiration.
Kremer JM. Kremer JM. Arthritis Rheumatol. 2020 Dec;72(12):1959-1962. doi: 10.1002/art.41451. Epub 2020 Oct 8. Arthritis Rheumatol. 2020. PMID: 32720443 No abstract available.
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.
Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, Moreland LW, O'Dell J, Winthrop KL, Beukelman T, Bridges SL Jr, Chatham WW, Paulus HE, Suarez-Almazor M, Bombardier C, Dougados M, Khanna D, King CM, Leong AL, Matteson EL, Schousboe JT, Moynihan E, Kolba KS, Jain A, Volkmann ER, Agrawal H, Bae S, Mudano AS, Patkar NM, Saag KG. Singh JA, et al. Among authors: kremer jm. Arthritis Care Res (Hoboken). 2012 May;64(5):625-39. doi: 10.1002/acr.21641. Arthritis Care Res (Hoboken). 2012. PMID: 22473917 Free PMC article. Review. No abstract available.
284 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page